
News|Articles|August 1, 2008
Formulary Digital Edition August 2008
Clinical updates from the 68th Scientific Sessions of the American Diabetes Association; Focus on tocilizumab; Drug Watch: Agents in late-stage development for the treatment of type 2 diabetes mellitus
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Zepbound linked to lower healthcare costs in older adults with obesity
2
Biosimilars provide modest cost savings for cancer patients, study finds
3
On Medicaid work requirements, the end of ACA enhanced subsidies and ACAP’s 25th anniversary
4
FDA approves Gilead’s Bixlenvo, smallest single-tablet option for virologically suppressed HIV patients
5

























